Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

37.98
+1.464.00%
Post-market: 37.980.00000.00%16:10 EDT
Volume:694.14K
Turnover:26.11M
Market Cap:2.93B
PE:-10.71
High:38.06
Open:36.74
Low:36.15
Close:36.52
52wk High:46.00
52wk Low:26.74
Shares:77.11M
Float Shares:71.60M
Volume Ratio:0.92
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5448
EPS(LYR):-3.0083
ROE:-37.65%
ROA:-25.52%
PB:4.62
PE(LYR):-12.63

Loading ...

Xenon Pharmaceuticals to Host Investor Webinar Showcasing Early-Stage Non-Opioid Pain Treatment Programs

Reuters
·
Yesterday

Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain

THOMSON REUTERS
·
Yesterday

Design Therapeutics Appoints Justin Gover to Board of Directors

THOMSON REUTERS
·
Sep 11

Xenon Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital

Dow Jones
·
Sep 02

BRIEF-Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Aug 30

Xenon Pharmaceuticals Announces New Equity Inducement Plan with 55,300 Share Options for New Employees

Reuters
·
Aug 30

Xenon Pharmaceuticals Inc : JP Morgan Cuts Target Price to $57 From $60

THOMSON REUTERS
·
Aug 18

Stock Track | Xenon Pharmaceuticals Soars 5% Intraday Following Analyst's Bullish Stance

Stock Track
·
Aug 13

Stock Track | Xenon Pharmaceuticals Soars 8.65% on Bullish Analyst Ratings and Price Targets

Stock Track
·
Aug 12

Wedbush Adjusts Price Target on Xenon Pharmaceuticals to $43 From $42, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

Stock Track | Xenon Pharmaceuticals Surges 7.01% Pre-market on Multiple Analyst Buy Ratings

Stock Track
·
Aug 12

Stock Track | Xenon Pharmaceuticals Soars 5.54% After Hours on Impressive Q2 Earnings Beat

Stock Track
·
Aug 12

Xenon Pharmaceuticals Q2 Loss Widens

MT Newswires Live
·
Aug 12

Xenon Pharmaceuticals Q2 EPS $1.07 Beats $(0.99) Estimate

Benzinga
·
Aug 12

Xenon Pharmaceuticals Reports Increased Q2 Net Loss of $84.7M Amid Higher R&D Expenses, Slight Decrease in Other Income

Reuters
·
Aug 12

Xenon Pharmaceuticals Q2 Income From Operations USD -94.229 Million

THOMSON REUTERS
·
Aug 12

Xenon Pharmaceuticals Inc expected to post a loss of 99 cents a share - Earnings Preview

Reuters
·
Aug 09

Xenon Pharmaceuticals Inc. to Release Second Quarter 2025 Financial Results

Reuters
·
Aug 04

Xenon Pharmaceuticals Announces New Equity Inducement Grants for Employees Under Nasdaq Rule 5635(c)(4)

Reuters
·
Aug 02

BRIEF-Xenon Pharmaceuticals Appoints Ian Mortimer As Interim CFO

Reuters
·
Jul 04